1.Herpes Simplex Virus 2 Infection Rate and Necessity of Screening during Pregnancy: A Clinical and Seroepidemiologic Study.
Il Dong KIM ; Ho Sun CHANG ; Kyung Jin HWANG
Yonsei Medical Journal 2012;53(2):401-407
PURPOSE: This study determined the seroprevalence of herpes virus 2 in gravidas and the differences between herpes virus 2-infected and healthy gravidas. The need to screen gravidas for herpes virus 2 was also evaluated. MATERIALS AND METHODS: A retrospective analysis involving 500 gravidas who underwent herpes virus 2 serologic testing and delivery in our hospital between January 2009 and August 2010 was performed. All patients in the study group were classified as herpes simplex virus 2 (HSV2) positive, and all cases were analyzed with respect to the clinical course of the pregnancy, pregnancy outcome, obstetric complications, and neonatal outcomes. SPSS software (version 14.0) was used for statistical analysis. A chi-square test and Student's t-test were used for statistical analysis. RESULTS: In the current study, the herpes virus 2 seroprevalence rate in gravidas was 17%. There was no significant difference in the rates of preterm delivery, premature rupture of membranes, preterm labor, and intrauterine growth restriction between the herpes virus 2-infected gravidas and the healthy control group. The rates of spontaneous abortion and sexually transmitted disease were higher in the herpes virus 2 infection group than the healthy control group. CONCLUSION: After educating gravidas on genital herpes and, if gravidas thereafter consent to herpes virus 2 screening, the risk of neonatal herpes virus 2 infections can be reduced. In addition, examination of gravidas for sexually transmitted diseases would increase as would appropriate treatment.
Adult
;
Female
;
Herpes Genitalis/*diagnosis/epidemiology/virology
;
Herpes Simplex
;
Herpesvirus 2, Human/*pathogenicity
;
Humans
;
Pregnancy
;
Pregnancy Complications, Infectious/diagnosis/epidemiology/virology
;
Retrospective Studies
2.Prevention of Cytomegalovirus Transmission via Breast Milk in Extremely Low Birth Weight Infants.
Hye Soo YOO ; Se In SUNG ; Yu Jin JUNG ; Myung Sook LEE ; Young Mi HAN ; So Yoon AHN ; Yun Sil CHANG ; Won Soon PARK
Yonsei Medical Journal 2015;56(4):998-1006
PURPOSE: Extremely low birth weight infants (ELBWIs) have a high risk of acquiring cytomegalovirus (CMV) infection via breast milk and consequently developing serious symptoms. We evaluated whether freeze-thawing or pasteurization could prevent postnatal CMV infection transmitted through breast milk in ELBWIs. MATERIALS AND METHODS: Medical records of 385 ELBWIs with whole milk feeding, and freeze-thawed or pasteurized breast milk feeding were reviewed retrospectively. Postnatally acquired CMV infection was defined as an initial negative and a subsequent positive on follow-up urine CMV DNA polymerase chain reaction screening tests. The incidence, clinical characteristics, symptoms, sequelae, and long-term outcome at corrected age [(CA): 2 years of CMV infection] were analyzed. RESULTS: While no infant developed CMV infection with whole milk (0/22) or pasteurized breast milk (0/62) feeding, postnatal CMV infection was diagnosed in 8% (27/301) of ELBWIs who were fed freeze-thawed breast milk. Gestational age in the CMV group was significantly lower than the control group. In 82% (22/27) of cases, CMV infection was symptomatic and was associated with increased ventilator days and > or =moderate bronchopulmonary dysplasia (BPD). Neurodevelopmental outcome and growth status at CA 2 years were not different between the study groups. Lower gestational age and freeze-thawed breast milk feeding >60% of total oral intake during the first 8 postnatal weeks were independent risk factors for acquiring postnatal CMV infection. BPD (> or =moderate) was the only significant adverse outcome associated with this CMV infection. CONCLUSION: Pasteurization but not freeze-thawing of breast milk eradicated the postnatal acquisition of CMV infection through breast milk.
Adult
;
Breast Feeding
;
Bronchopulmonary Dysplasia
;
Cytomegalovirus/*isolation & purification
;
Cytomegalovirus Infections/epidemiology/prevention & control/*transmission
;
Female
;
Gestational Age
;
Humans
;
Incidence
;
Infant
;
*Infant, Extremely Low Birth Weight
;
Infant, Newborn
;
Infectious Disease Transmission, Vertical/*prevention & control
;
Male
;
Milk, Human/chemistry/*virology
;
Polymerase Chain Reaction
;
Pregnancy
;
Pregnancy Complications, Infectious/diagnosis
;
Retrospective Studies
;
Risk Factors